BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19875703)

  • 1. Kupffer cell activation is a causal factor for hepatic insulin resistance.
    Lanthier N; Molendi-Coste O; Horsmans Y; van Rooijen N; Cani PD; Leclercq IA
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G107-16. PubMed ID: 19875703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet.
    Lanthier N; Molendi-Coste O; Cani PD; van Rooijen N; Horsmans Y; Leclercq IA
    FASEB J; 2011 Dec; 25(12):4301-11. PubMed ID: 21873555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.
    Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice.
    Lebrun V; Molendi-Coste O; Lanthier N; Sempoux C; Cani PD; van Rooijen N; Stärkel P; Horsmans Y; Leclercq IA
    Clin Sci (Lond); 2013 Dec; 125(11):501-11. PubMed ID: 23758436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.
    Neyrinck AM; Cani PD; Dewulf EM; De Backer F; Bindels LB; Delzenne NM
    Biochem Biophys Res Commun; 2009 Jul; 385(3):351-6. PubMed ID: 19463788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
    Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model.
    Kim SP; Ellmerer M; Kirkman EL; Bergman RN
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1581-9. PubMed ID: 17284579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
    Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.
    Davis JE; Gabler NK; Walker-Daniels J; Spurlock ME
    Obesity (Silver Spring); 2008 Jun; 16(6):1248-55. PubMed ID: 18421279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.
    Buettner R; Bettermann I; Hechtl C; Gäbele E; Hellerbrand C; Schölmerich J; Bollheimer LC
    Horm Metab Res; 2010 Oct; 42(11):769-74. PubMed ID: 20803414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
    Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
    Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
    Basciano H; Miller AE; Naples M; Baker C; Kohen R; Xu E; Su Q; Allister EM; Wheeler MB; Adeli K
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E462-73. PubMed ID: 19509184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice.
    de Leeuw van Weenen JE; Hu L; Jansen-Van Zelm K; de Vries MG; Tamsma JT; Romijn JA; Pijl H
    Brain Res; 2009 Jan; 1250():141-8. PubMed ID: 19028458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
    Mercader J; Ribot J; Murano I; Feddersen S; Cinti S; Madsen L; Kristiansen K; Bonet ML; Palou A
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.